PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 21, 2008 Subscribe to this News Feed    
 

New Device for Treating Aneurysms in Portneuf Heart & Vascular Surgeons Hands

The Food and Drug Administration (FDA) approved the Talent Abdominal Stent Graft System on April 16, 2008 and the device is still in a limited market release. Since the FDA's approval, only nine Talent Abdominal devices have been implanted in the Northwest region - three of them by Drs DeLaRosa and Vasquez this past week in Pocatello, Idaho.

Pocatello, ID (PRWEB) May 21, 2008 -- Earlier this week, Drs Jacob DeLaRosa and Julio Vasquez, surgeons at Portneuf's Heart and Vascular Center, performed one of the most advanced surgeries for treating Abdominal Aortic Aneurysms (AAA). An aneurysm is a bulge or balloon that forms in the wall of a blood vessel and is most commonly a result of an accumulation of fatty deposits on the vessel wall.

The Food and Drug Administration (FDA) approved the Talent Abdominal Stent Graft System on April 16th, and the device is still in a limited market release. Since the FDA's approval, only nine Talent Abdominal devices have been implanted in the Northwest region - three of them by Drs. DeLaRosa and Vasquez this past week. As an endovascular center of excellence for the treatment of Abdominal Aortic Aneurysms, Portneuf Medical Center has quickly become one of the highest Talent implanting hospitals in the Pacific Mountain region.

An aneurysm is a bulge or balloon that forms in the wall of a blood vessel, usually due to an accumulation of fatty deposits on the vessel wall, but may relate to heredity, trauma or other disease that weakens the vessel wall. If an aneurysm forms in the part of the aorta (one of the body's main blood vessels) that extends through the abdomen, it is called an abdominal aortic aneurysm. An abdominal aortic aneurysm is treated if the doctor feels there is a risk that the aneurysm will burst (rupture).

There are two treatment options available: open surgical repair and endovascular stent grafting. With open surgical repair, the surgeon accesses the aneurysm through an incision in the abdomen. Patients typically spend one night in an intensive care unit and remain in the hospital for an additional five to seven days.

With the new Talent Abdominal stent device, the endovascular procedure typically takes one to two hours and the patients are often sent home the following day. A woven polyester tube (graft) covered by a tubular metal web (stent) is inserted into the body through the femoral artery via small groin incisions.

Present in an estimated 1.2 million people and responsible for approximately 15,000 annual deaths in the United States, ruptured AAAs are currently the 10th leading cause of death among U.S. men over age 55, with fewer than 20 percent of people surviving their rupture. Early detection through painless ultrasound screening and minimally invasive treatment with endovascular repair (EVAR) have historically shown a significant improvement in the survival rate for patients of all ages.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1FbXB0LUluc2UtWmV0YS1DcmFzLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Stacey Holcomb
Portneuf Medical Center
2082392580
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move